Overactive Bladder

Long-Term Safety of Overactive Bladder Medications in Men Receiving Pharmacotherapy for Benign Prostatic Enlargement: A Real-World Study Using Inverse Probability of Treatment Weighting - Beyond the Abstract July 1, 2026

Irritable bowel syndrome subtype predicts treatment response and defines distinct mechanistic phenotypes in OAB-IBS comorbidity: a prospective observational study. June 26, 2026

Unequal Utilization of Overactive Bladder Treatment: The Role of Socioeconomic and Insurance Disparities. June 21, 2026

Ambulatory Posterior Tibial Nerve Stimulation Using TENSI+ Device: First Clinical Study in Patients with Overactive Bladder and Detrusor Overactivity in Spain. June 14, 2026

Sociodemographic Factors and Overactive Bladder Treatment and Follow-up Patterns. June 7, 2026

Navigating the challenges of overactive bladder management in women. June 7, 2026

Neuromodulation techniques for managing overactive bladder. May 31, 2026

Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013-2018 NHANES. May 31, 2026

Chinese American Women's Overactive Bladder Care Experience: A Qualitative Study. May 24, 2026

Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study. May 24, 2026

The Risk of Incident Dementia Following Anticholinergic Treatment or Mirabegron Use for Overactive Bladder: A Different Set of Findings July 1, 2026

Longitudinal Changes in Overactive Bladder Symptoms After Prostatic Urethral Lift for Benign Prostatic Hyperplasia: A Japanese Single-Center Prospective Study. June 26, 2026

Urinary Biomarkers and Response to Treatment in Overactive Bladder (OAB): A Systematic Review and Meta-Analysis. June 21, 2026

Assessing the Effectiveness of "Onabotulinumtoxin A" (Botox®) Intradetrusor Injection for Overactive Bladder (OAB) Patients After Medical Therapy Failure. June 14, 2026

The Administrative Burden of Overactive Bladder Medications. June 7, 2026

Efficacy of behavioral therapy and different dosages of mirabegron for the treatment of male overactive bladder patients. June 7, 2026

Prevalence and risk factors of overactive bladder syndrome among Egyptian medical students, and its impact on health-related quality of life, cross-sectional study. May 31, 2026

Impact of Adjunctive Myo-Inositol and Magnesium Therapy on Paediatric Overactive Bladder: A Retrospective Analysis. May 31, 2026

Decision-Making in Refractory Overactive Bladder: Evaluation of a Novel Patient Decision Aid and its Impact on Decisional Conflict. May 24, 2026

The Overactive and Poorly Compliant Bladder: a Review of Coexisting Detrusor Overactivity and Poor Compliance May 18, 2026

Page 1 of 140